ICTS conducts clinical trials across multiple therapeutic areas. Credit: fernando zhiminaicela/Pixabay.

Integrated clinical trial network Eximia Research has expanded into Iowa, US, with the acquisition of Integrated Clinical Trial Services (ICTS).

This move is expected to enhance access to advanced clinical trials and healthcare solutions across the country.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Based in West Des Moines, ICTS is said to be the region’s only full-time dedicated research clinic and conducts clinical trials in various therapeutic areas.

The clinic focuses on raising awareness about the value of clinical trials among the public and medical professionals.

Kristine Majors, a registered nurse, alongside her husband Joe, has led the clinic, which brings more than 19 years of academic and clinical research experience to the Eximia network.

See Also:

They have developed ICTS into a multidisciplinary research site, contributing to the advancement of new treatments.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The integration of ICTS into Eximia’s network is expected to improve access to clinical trials and treatments for the West Des Moines community.

Eximia Research CEO Ella Grach said: “The addition of this established, successful site strengthens our ability to offer cutting-edge clinical trials to more communities and reinforces our commitment to expanding access to quality clinical research.

“With their experienced leadership and focus on patient care, particularly in paediatrics, metabolic disorders and a wide range of other therapeutic areas, ICTS is a perfect fit for our growing network.”

This partnership is expected to have a positive effect on healthcare in the region, complementing Eximia’s presence in the Midwest, which includes Sundance Clinical Research in St. Louis, and other sites across the mid-Atlantic, south-east and western US.

In August, Eximia Research announced the acquisition of Tidewater Clinical Research, which works on women’s health and ophthalmology clinical trials in the Hampton Roads/Eastern Virginia region in the US.